Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, June 23, 2018
New diabetes drug may help people with obesity lose weight
›
In continuation of my update on semaglutide A compound that mimics a naturally occurring hormone that regulates appetite ma...
Friday, June 22, 2018
Drug used to treat daytime sleepiness does not appear to improve driving in those with sleep apnea
›
Armodafinil In "Does Armodafinil Improve Driving Task Performance and Weight Loss in Sleep Apnea? A Randomized Trial,"...
Thursday, June 21, 2018
Novartis Drug Tasigna Approved by FDA to Treat Children with Rare Form of Leukemia
›
In continuation of my update on Nilotinib Novartis announced today that the US Food and Drug Administration (FDA) expanded t...
Wednesday, June 20, 2018
Oral drug reduces venous thromboembolism recurrence among cancer patients
›
In continuation of my update on rivaroxaban Research from the University of Warwick indicates that taking a tablet a day can help trea...
Tuesday, June 19, 2018
Osteoporosis drug may be cardioprotective in hip fracture patients
›
In continuation of my update on alendronate The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, he...
Saturday, June 16, 2018
New drug reduces symptoms of Rett syndrome in preclinical models
›
A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons cha...
Wednesday, June 13, 2018
FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms
›
In continuation of my update on mirabegron Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has app...
Tuesday, June 12, 2018
Mepivacaine is found to be an effective spinal anesthetic for knee replacement surgery
›
A numbing medicine largely abandoned decades ago for pain control during surgery could be making a comeback as an effective spinal anesthe...
Saturday, June 9, 2018
FDA Approves Tafinlar + Mekinist for the Treatment of BRAF-Positive Anaplastic Thyroid Cancer
›
In continuation of my update on Tafinlar ( dabrafenib ) and Mekinist ( trametinib ) The U.S. Food and Drug Administration approved...
Friday, June 8, 2018
Methylene blue could hold the key to future anti-aging treatment
›
In continuation of my update on Methylene Blue In a keynote address to the 19 th World Dermatology Congress, renowned dermatologist Dr...
Thursday, June 7, 2018
Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints
›
Knopp Biosciences LLC today announced the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereos...
Wednesday, June 6, 2018
Study identifies molecule that may be critical to repair of white matter
›
In continuation of my update on hyaluronic acid (HA) A new study identifies a molecule that may be critical to the repair of whit...
Tuesday, June 5, 2018
Osteoporosis drug prevents spread of basal-like breast cancer in mice
›
In continuation of my update on zoledronic acid Researchers in China have discovered that an enzyme called UGT8 drives the progressio...
Saturday, June 2, 2018
Baldness treatment using a medication for osteoporosis
›
According to study leader Nathan Hawkshaw, of the University of Manchester in England, this new drug has never been considered in the trea...
Friday, June 1, 2018
ONC201 disrupts mitochondrial function and kills breast cancer cells, reveals study
›
TRAIL, a member of the TNF family of ligands, causes caspase-dependent apoptosis through activation of its receptors, death receptor 4 a...
‹
›
Home
View web version